Home » Newsletters » BioWorld Asia

BioWorld Asia

May 23, 2001

View Archived Issues

Zentaris Plans IPO In Germany To Fund 14 Pipeline Projects

Gene With Role In Malaria May Have Autoimmune Implications

NicOx Raises US$49M Through Public, Private Share Offering

UK Biotech Officials Need Better, More Open Dialogue With Public

Other News To Note

Crucell Enters Diabetes Deal Around Work At UMC Utrecht

European Industry Argues For No Change In GMO Labeling

Hybrigenics, Lynx Discover New Obesity Drug Target, Extend Deal

Specific Skills Required To Negotiate Beneficial Deals

CAT Enters Deal For Antibodies Against Two Immunex Targets

Memorec Completes EUR12.8M Round For Microarray Programs

EMEA Developing Guidelines For Use Of Transgenic Plants

Mindsense Biosystems Secures $2M For Biomarkers Technology

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026